1245816-29-8 Usage
General Description
2-oxa-6-azaspiro[3.5]nonane-6-carboxylic acid tert-butyl ester is a complex chemical compound that is characterized by its specific structure: a spirocyclic system that consists of one pyrrolidinone ring and one oxane ring. It can be identified by its CAS number, which is a global identifier assigned to chemicals. The tert-butyl ester group in its structure suggests that it is a derivative of carboxylic acid and may have ester-like properties, which often include volatility, stability, and the production of sweet odors. Its unique structure indicates it may have multiple diverse applications, possibly within industries such as pharmaceuticals, agrochemicals, and materials science. Like with all chemicals, it must be handled with care according to safety data sheets to prevent harm or injury.
Check Digit Verification of cas no
The CAS Registry Mumber 1245816-29-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,5,8,1 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1245816-29:
(9*1)+(8*2)+(7*4)+(6*5)+(5*8)+(4*1)+(3*6)+(2*2)+(1*9)=158
158 % 10 = 8
So 1245816-29-8 is a valid CAS Registry Number.
1245816-29-8Relevant articles and documents
2-ACYLAMINOTHIAZOLE DERIVATIVE AND SALT THEREOF
-
, (2016/01/25)
[Problem] A compound which is useful as an active ingredient of a pharmaceutical composition for treating storage dysfunctions, voiding dysfunctions, and lower urinary tract diseases is provided. [Means for Solution] The present inventors have found that a thiazole derivative having pyrazine-2-carbonylamino substituted at the 2-position is an excellent muscarinic M3 receptor positive allosteric modulator, and is useful as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M3 receptor, thereby completing the present invention. The 2-acylaminothiazole derivative or a salt thereof of the present invention can be used as an agent for preventing and/or treating bladder or urinary tract diseases, related to bladder contraction by a muscarinic M3 receptor, for example, voiding dysfunctions such as underactive bladder.
